Who
Patrick J. Zenner
Director
Company insider
Files Form 4 as: Director, Cartesian Therapeutics; Director, West Pharmaceutical Services; Director, Arqule; Director, Par Pharmaceutical Companies; Director, Geron; Director, Curagen; Exec. Chairman & Interim CEO, Exact Sciences; Director, Xoma Ltd /de/.
In numbers
- Trades disclosed
- 197
- Buys
- 16
- Sells
- 10
- Bought
- $387K
- Sold
- $2.4M
- Companies
- 11
- Companies where not an officer
- 10
- First trade
- 3 Feb 2006
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,800 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,600 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —228,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | RNAC Cartesian TherapeuticsBiotechnology | SEC FORM 4 Code A | —178,000 at $0.00 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —12,820 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —20,000 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
| 13 Nov 2023filed 15 Nov 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | $70K75,000 at $0.93 | filing |
| 2 Jan 2023filed 4 Jan 2023 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 31 Mar 2022filed 1 Apr 2022 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K49 at $410.71 | filing |
| 3 Jan 2022filed 5 Jan 2022 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 9 Sep 2021filed 13 Sep 2021 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code G | —11,517 at $0.00 | filing |
| 4 May 2021filed 13 Sep 2021 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code G | —310 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.